These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2885007)

  • 1. Circadian phase dependency of the effects of different beta-receptor blocking drugs on motor activity of rats. Importance of drug lipophilicity.
    Lemmer B; Neumann G
    Arzneimittelforschung; 1987 Mar; 37(3):321-5. PubMed ID: 2885007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of synaptosomal [3H]noradrenaline uptake by beta-adrenoceptor blocking drugs: influence of lipophilicity.
    Street JA; Walsh A
    Eur J Pharmacol; 1984 Jul; 102(2):315-24. PubMed ID: 6148250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative inotropic effects and the hydrophobicity of beta-adrenergic blocking agents.
    Harada S; Ban T; Fujita T; Koshiro A
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):262-71. PubMed ID: 6118107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of intra-cisternal beta-blocking agents in dogs with acute nerogenic hypertension.
    Montastruc JL; Montastruc P
    Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):275-81. PubMed ID: 39526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.
    Hong CY; Turner P
    Br J Clin Pharmacol; 1982 Aug; 14(2):269-72. PubMed ID: 6125206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat.
    Hellenbrecht D; Enenkel J
    Arzneimittelforschung; 1984; 34(9):980-3. PubMed ID: 6150722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central action of drugs influencing beta-adrenergic receptor. part V. The interaction of drugs affecting beta-adrenergic receptor in motility test.
    Ksiaz A; Kleinrok Z
    Pol J Pharmacol Pharm; 1975; 27(6):595-601. PubMed ID: 1714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific and circadian-phase-dependent kinetic behavior of d,l-, l-, and d-propranolol in plasma, heart, and brain of light--dark-synchronized rats.
    Lemmer B; Bathe K
    J Cardiovasc Pharmacol; 1982; 4(4):635-44. PubMed ID: 6181339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
    Tachikawa S; Takenaka T; Maeno H
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
    Suemaru K; Gomita Y; Furuno K; Araki Y
    Pharmacol Biochem Behav; 1993 Sep; 46(1):131-3. PubMed ID: 7902979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of central beta-adrenoceptors attenuates tremor induced by 5-hydroxytryptamine (5-HT)-receptor activation in rats.
    Hallberg H
    Acta Physiol Scand; 1987 Mar; 129(3):421-8. PubMed ID: 2883812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-blocking agents and angiotensin II on isoproterenol-stimulated renin release from rat kidney slices.
    Capponi AM; Gourjon M; Vallotton MB
    Circ Res; 1977 May; 40(5 Suppl 1):I89-93. PubMed ID: 15737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
    Robbiano L; Martelli A; Allavena A; Mazzei M; Gazzaniga GM; Brambilla G
    Cancer Res; 1991 May; 51(9):2273-9. PubMed ID: 1673086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative effects of seven beta adrenolytic agents on blood pressure after injection into the posterior hypothalamus of rats. The frequency heart and the plasma renin activity (author's transl)].
    Bentue-Ferrer D; Allain H; Van den Driessche J; Pape D; Reymann JM
    J Pharmacol; 1981; 12(2):161-77. PubMed ID: 6115097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency-dependent block of nerve conduction by beta-adrenergic blocking agents.
    Sada H; Ban T
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):134-44. PubMed ID: 6121535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.